CD40LG and Hepatitis: Therefore, it is necessary to implement strict blood screening and monitoring measures for high-risk patients, especially immunosuppressed patients, to reduce the risk of transmission of TTIs-HEV and improve patient outcomes.[19] This case advocates active HEV-IgM surveillance in transfusion recipients with unexplained hepatitis, even if serological results are negative.